Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phospho-ubiquitin relay: a modular switch for plant immune fine-tuning.

Science China. Life sciences·2026
Same author

Synthesis, optical properties, energy transfer mechanisms, and mechanical characteristics of NaLa(MoO<sub>4</sub>)<sub>2</sub>: Er<sup>3+</sup>, Nd<sup>3+</sup> co-doped phosphors.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Market-based versus collective self-governance in irrigation systems: Differential effects on infrastructure condition.

Journal of environmental management·2026
Same author

Metal-driven nanoassembly of hexahistidine-tagged melittin enables superior phytopathogen biofilm degradation with attenuated toxicity.

Journal of nanobiotechnology·2026
Same author

PUB13-Mediated Degradation of PBS3 Regulates Salicylic Acid Biosynthesis to Coordinate Plant Immunity and Leaf Longevity.

Plant communications·2026
Same author

Exploration of common immune mechanisms and hub genes in latent and active tuberculosis infection.

Frontiers in cellular and infection microbiology·2026

Related Experiment Video

Updated: Mar 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.4K

Thrombolysis based on magnetically-controlled surface-functionalized Fe3O4 nanoparticle.

Ming Chang1,2, Yu-Hao Lin2, Jacque Lynn Gabayno3

  • 1a College of Mechanical Engineering and Automation , Huaqiao University , Xiamen, Fujian , China.

Bioengineered
|October 1, 2016
PubMed
Summary

Magnetically controlled urokinase-coated iron oxide nanoparticles significantly enhance thrombolysis, improving clot removal rates by 50% in microfluidic channels. This magnetic manipulation offers a novel approach for effective clot dissolution.

Keywords:
Fe3O4 nanoparticlesmagnetic-controlmagnetically-activated microablationsurface-functionalizedthrombolysisurokinase

More Related Videos

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.4K
Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection
15:03

Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection

Published on: June 16, 2020

10.1K

Related Experiment Videos

Last Updated: Mar 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.4K
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.4K
Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection
15:03

Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection

Published on: June 16, 2020

10.1K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Hematology

Background:

  • Thrombolysis is crucial for treating thrombotic diseases.
  • Current thrombolytic therapies have limitations.
  • Magnetic nanoparticles offer potential for targeted drug delivery.

Purpose of the Study:

  • To investigate magnetic field control of urokinase-coated iron oxide nanoparticles for enhanced thrombolysis.
  • To evaluate the efficacy of magnetically manipulated nanoparticles in a microfluidic thrombolysis model.

Main Methods:

  • Surface-functionalization of Fe3O4 nanoparticles with urokinase.
  • Characterization using particle size distribution, zeta potential, and spectroscopy.
  • In vitro thrombolysis tests in a microfluidic channel under magnetic field control.

Main Results:

  • Magnetically controlled urokinase-coated Fe3O4 nanoparticles showed a 50% increase in thrombolysis rate compared to urokinase alone.
  • Nearly complete thrombus removal was achieved in the microfluidic channel.
  • A 10.32 mg thrombus mass was fully removed in approximately 180 seconds.

Conclusions:

  • Magnetic manipulation of urokinase-coated Fe3O4 nanoparticles significantly improves thrombolysis efficiency.
  • This approach offers a promising method for targeted and accelerated clot dissolution.
  • The magnetically-activated microablation process prevents blood bolus formation during thrombolysis.